Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Non/invasive
Recent news which mentions Non/invasive
OncoBeta introduces Rhenium-SCT for non-melanoma skin cancer patients at Hospital Universitario 12 de Octubre
June 20, 2024
Tags
Spain
Non/invasive
Madrid
From
PRLog
GenesisCare and OncoBeta announce partnership to provide innovative treatment for non-melanoma skin cancer
May 17, 2023
Tags
OncoBeta GmbH
Australia
New South Wales
From
PRLog
Latest research shows Australians still not getting annual skin checks with a Health Professional
March 01, 2023
Tags
Health
Bavaria
Science
From
PRLog
London skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
September 27, 2022
Tags
EPIC/Skin
Non/invasive
London, Greater
From
PRLog
German skin cancer patients join the EPIC-Skin study
July 28, 2022
Tags
Germany
Skin Cancer Therapy
Painless
From
PRLog
Sydney skin cancer patients join the EPIC-Skin study as they undergo first treatments with OncoBeta's Rhenium-SCT
April 13, 2022
Tags
Australia
Research
Beauty
From
PRLog
EPIC-Skin study welcomes world-first skin cancer patients treated with OncoBeta's Rhenium-SCT
March 10, 2022
Tags
United States
Italy
OncoBeta
From
PRLog
OncoBeta receives ethics approval for EPIC-Skin study to evaluate Rhenium-SCT in Australia
December 21, 2021
Tags
Munich
Beauty
NMSC therapy
From
PRLog
South African non-melanoma skin cancer patients now have greater access in the area of Johannesburg to innovative non-invasive treatment Rhenium-SCT®
November 16, 2021
Tags
Health
Bavaria
Rhenium/SCT
From
PRLog
Australian Nuclear Science and Technology Organization (ANSTO), the new production partner of OncoBeta® GmbH in Australia
July 13, 2021
Tags
Sydney
Non/invasive
Single/session
From
PRLog
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.